• 10 tips to find bargains

    Susan Erasmus gives advice on how bargain hunters can get the most bang for their buck.

  • Inside Labour

    Labour's bitter breaches need to be seen in historical context, says Terry Bell.

  • Rich getting richer

    Economists differ on how to tackle the chasm between rich and poor, says Leopold Scholtz.

Loading...
See More

Mediclinic eyes R5bn in rights offer

Aug 01 2012 08:50 I-Net Bridge

Company Data

REMGRO LIMITED [JSE:REM]

Last traded 266
Change -2
% Change -1
Cumulative volume 1141531
Market cap 0

Last Updated: 24-04-2015 at 05:00. Prices are delayed by 15 minutes. Source: McGregor BFA

MEDICLINIC INTERNATIONAL LIMITED [JSE:MDC]

Last traded 131
Change -2
% Change -2
Cumulative volume 1262847
Market cap 0

Last Updated: 24-04-2015 at 05:00. Prices are delayed by 15 minutes. Source: McGregor BFA

Related Articles

Mediclinic boasts 10.7% rise in H1 profit

Mediclinic firmly behind NHI

Mediclinic rejects pricing criticism

Medi-Clinic’s Swiss roll-out

Medi-Clinic spends big in SA

Medi-Clinic full-year profit flat

 

Johannesburg - South African private hospital group Mediclinic Corporation [JSE:MDC] said on Wednesday it plans to raise R5bn through a rights offer to refinance debt and to fund expansion.

Mediclinic, which operates hospitals in South Africa, Switzerland and the United Arab Emirates, said it would issue 174.6 million new shares at R28.63 per share.

That represents a 25% discount to the stock’s 30-day volume weighted average price.

Existing shareholders will be able to purchase 26.8 new shares for every 100 held.

Mediclinic said the proceeds would be used to refinance its existing debt of about R28bn, which is denominated in both the South African rand and the Swiss franc.

“The refinancing provides the group with the appropriate capital structure to pursue strategic growth and development opportunities, while significantly reducing financing costs,” it said in a statement. 

The rights offer is fully underwritten by Remgro [JSE:REM].

Among the conditions for the deal is approval from Mediclinic shareholders.

Shares of Mediclinic are up 16% so far this year, outperforming an 8.2% rise in Johannesburg’s All Share [JSE:J203] index.


 
mediclinic

NEXT ON FIN24X

 
 
 

Read Fin24’s Comments Policy

24.com publishes all comments posted on articles provided that they adhere to our Comments Policy. Should you wish to report a comment for editorial review, please do so by clicking the 'Report Comment' button to the right of each comment.

Comment on this story
0 comments
Add your comment
Comment 0 characters remaining
 

Company Snapshot

Brought to you by BizNews

More from BizNews

We're talking about:

SMALL BUSINESS

Johannesburg has been selected to host the Global Entrepreneurship Congress in 2017. "[The congress] will ensure that small business development remains firmly on the national agenda and the radar screen of all stakeholders, the Small Business Development minister said.
 
 

Top 10 richest musicians of all time

Check out the gallery to find out who they are!

 
 

Luxury living

Seven of the most expensive children's toys ever made
5 millionaires turned murderers
The youngest billionaires in the world and how they made it
Watch: Flying first class has never been this luxurious!

Money Clinic

Money Clinic
Do you have a question about your finances? We'll get an expert opinion.
Click here...

Voting Booth

How do you see your boss? He/sheis:

Previous results · Suggest a vote

Loading...